Eaton Vance Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Eaton Vance Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,664	Closed	-$440K	–	2896
2021 Q2	$440K	Buy	2,664 +1,146	+75%	+$191K	﹤0.01%	1371
2021 Q1	$233K	Buy	+1,518	New	+$206K	﹤0.01%	1431
2020 Q1	–	Sell	-7,266	Closed	-$808K	–	1362
2019 Q4	$808K	Buy	+7,266	New	+$747K	﹤0.01%	1045

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Eaton Vance Management's PRAH Position: Q3 2021 in Review

Eaton Vance Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 2,664 shares — an estimated $440K sold.

Eaton Vance Management first reported a position in PRAH in Q4 2019 and held it in 3 quarters. The position peaked at $808K in Q4 2019. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Eaton Vance Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Eaton Vance Management sold 2,664 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $440K.
Eaton Vance Management first reported a position in PRA Health Sciences, Inc. in Q4 2019 and held it in 3 quarters.
Eaton Vance Management's PRA Health Sciences, Inc. position peaked at $808K in Q4 2019.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Eaton Vance Management's 13F filing for Q3 2021, filed 15 Nov 2021.